Myocardial CD36 expression and fatty acid accumulation in patients with type I and II CD36 deficiency

Annals of Nuclear Medicine

Volumn 12, Issue 5, 1998, Pages 261-266

  Watanabe, Kenichi ^a   Ohta, Yoshimi ^a   Toba, Ken ^b   Ogawa, Yusuke ^b   Hanawa, Haruo ^b   Hirokawa, Yoichi ^b   Kodama, Makoto ^b   Tanabe, Naohito ^b   Hirono, Satoru ^b   Ohkura, Yuji ^b   Nakamura, Yuichi ^b   Kato, Kiminori ^b   Aizawa, Yoshifusa ^b   Fuse, Ichiro ^b   Miyajima, Seiichi ^c   Kusano, Yoriko ^c   Nagamoto, Takafumi ^a   Hasegawa, Go ^b   Naito, Makoto ^b  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c Tsubame Rosai Hospital

Author keywords

123I BMIPP; Cardiomyopathy; CD36 deficiency; Fatty acid metabolism; Heart disease

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; CD36 ANTIGEN; LONG CHAIN FATTY ACID;

ADULT; AGED; ARTICLE; CAPILLARY ENDOTHELIUM; DISEASE ASSOCIATION; FATTY ACID METABOLISM; FEMALE; FLOW CYTOMETRY; HEART DISEASE; HEART MUSCLE CAPILLARY; HEART MUSCLE METABOLISM; HEART SCINTISCANNING; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; RADIOISOTOPE DISTRIBUTION; RECEPTOR INTRINSIC ACTIVITY; THROMBOCYTE;

EID: 0031738276     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164911     Document Type: Article

References (20)

1. Kudoh T, Tamaki N, Magata Y, Konishi J, Nohara R, Iwasaki A, et al. Metabolism substrate with negative myocardial uptake of Iodine-123-BMIPP. J Nucl Med 38: 548-553, 1997.
2. Tanaka T, Sohmiya, Kawamura K. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol 29: 121-127, 1997.
3. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268: 11811-11816, 1993.
4. Yamamoto N, Akamatu N, Sakuraba H, Yamazaki H, Tanoue K. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood 83: 392-397, 1994.
5. Kashiwagi H, Tomiyama Y, Honda S, Kosugi S, Shiraga M, Nagao N, et al. Molecular basis of CD36 deficiency - Evidence that a 478C-T substitution (proline 90-serine) in CD36 cDNA accounts for CD36 deficiency. J Clin Invest 95: 1040-1046, 1995.
6. Nozaki S, Kashiwagi H, Yamashita S, Nakagawa T, Kostner B, Tomiyama Y, et al. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36 deficient subjects. J Clin Invest 96: 1859-1865, 1995.
7. Greenwalt DE, Scheck SH, Rhinehart-Jones T. Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J Clin Invest 96: 1382-1388, 1995.
8. 123I-BMIPP myocardial accumulation in patients with type I and II CD36 deficiency. KAKU IGAKU (Jpn J Nucl Med) 34: 1125-1130, 1997.
9. Watanabe K, Toba K, Ogawa Y, Kodama M, Hirono S, Ohkura Y, et al. Hypertrophic cardiomyopathy with type I CD36 deficiency. Jpn Circulation J 62: 541-542, 1998.
10. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using branched fatty acid analog. J Nucl Med 33: 659-667, 1992.
11. Clark JB, Clark CMJ. The growth and metabolism of the developing heart. In: Jones CT, ed. Biochemical Development of the Fetus and Neonate. New York: Elsevier Biomedical Press, pp. 185-212, 1982.
12. Bremer J, Osmundsen H. Fatty acid oxidation and its regulation. In: Numa S, ed. Fatty Acid Metabolism and Its Regulation. New York: Elsevier Science Publishers, pp. 113-154, 1984.
13. Stremmel W. Fatty acid uptake by isolated rat heart myocytes represents a carrier-mediated transport process. J Clin Invest 81: 844-852, 1988.
14. Schaffer JE, Lodish HF. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 79: 427-436, 1994.
15. Kusaka Y, Tanaka T, Okamoto F, Terasaki F, Matsunaga Y, Miyazaki H, et al. Effects of sulfo-N-succinimidyl palmitate on the rat heart: myocardial long-chain fatty acid uptake and cardiac hypertrophy. J Mol Cell Cardiol 27: 1605-1612, 1995.
16. Kashiwagi H, Tomiyama Y, Kosugi S, Shiraga M, Lipsky R, Kanayama Y, et al. Identification of molecular defects in subject with type I CD36 deficiency. Blood 83: 3545-3552, 1994.
17. Huang MM, Bolen JB, Barnwall JW, Shattil SJ, Brugge JS. Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. Proc Natl Sci USA 88: 7844-7848, 1991.
18. Abumrad NA, El-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation-Homology with human CD36. J Biol Chem 268: 17665-17668, 1993.
19. a, on platelet membrane glycoprotein IV. Blood 75: 684-687, 1990.
20. Yamamoto N, Ikeda H, Tandon NN, Herman J, Tomiyama Y, Mitani T, et al. A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: naka platelets lack detectable GP IV (CD36). Blood 76: 1698-1703, 1990.